e-learning
resources
Monograph
2015
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Re-assessing the importance of FEV
1
decline
Jørgen Vestbo, Peter Lange
Source:
Eur Respir Monogr 2015; 69: 134-142
Journal Issue:
Controversies in COPD
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Jørgen Vestbo, Peter Lange. Re-assessing the importance of FEV
1
decline. Eur Respir Monogr 2015; 69: 134-142
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Individual decline of FEV1 show diversity in COPD
Source: Annual Congress 2012 - Environmental exposure and other risk factors for airway diseases
Year: 2012
FVC decline over 1 year predicts mortality but not subsequent FVC decline in patients with IPF
Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside
Year: 2017
LVRS does not accelerate rate of decline in FEV
1
Source: Eur Respir J 2003; 22: Suppl. 45, 369s
Year: 2003
Has the determination of the rate of decline of FEV1 added value in addition to the determination of FEV1/FVC and FEV1
Source: International Congress 2016 – Man versus machine: waves, frequency, and more in lung function
Year: 2016
1 year RV/TLC change as a predictor of long term decline of FEV1
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
FEV1 decline in occupational asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 488s
Year: 2003
Prediction of all cause mortality in a population sample is improved by using FEV
1
quotient
Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases
Year: 2005
Within session variability of FEV1 and FVC pre- and post-bronchodilation
Source: International Congress 2019 – Quality, performance and interpretation of lung function testing
Year: 2019
Midflows do not vary independently of FEV1 and FVC
Source: Annual Congress 2010 - Quality measurement and improvement in lung function
Year: 2010
Maximally attained level of FEV
1
and FEV
1
decline determine airway hyperresponsiveness in adults
Source: Eur Respir J 2003; 22: Suppl. 45, 17s
Year: 2003
The evaluation of different factors that cause FEV1 decline in patients with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 135s
Year: 2001
When is FEV
1
loss excessive? – an investigation of the relationship between year-to-year and long-term spirometry changes
Source: Annual Congress 2004 - Longitudinal studies and determinants of lung function and COPD
Year: 2004
Association between weight loss and decline in FVC in patients with IPF
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019
The influence of FVC manoeuvres on consecutive FEV
1
values during methacholine challenge
Source: Eur Respir J 2004; 24: Suppl. 48, 587s
Year: 2004
Annual decline in forced expiratory volume in 1 sec (FEV1) in patients with COPD before and after introduction of tiotropium
Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Year: 2008
Exploring the clinical utility of measuring reversibility in mid expiratory flow and its relationship with FEV1 reversibility in patients with asthma.
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017
The relationship between long-term correlations (self-similarity) in PEF and FEV1 in COPD
Source: Annual Congress 2012 - New issues in pulmonary function
Year: 2012
FEV6 and FEV1/FEV6 have higher association with small airway function and oxygen saturation than FVC and FEV1/FVC in patients with asthma.
Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers
Year: 2020
Changes in spirometry (FVC and FEV
1
) in a closed population of COPD patients using new standarized values for Mexican people
Source: Eur Respir J 2003; 22: Suppl. 45, 69s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept